Xintela (Stockholm: XINT)

Last close As at 20/06/2024

2.56

−0.04 (−1.54%)

Market capitalisation

229m

Edison Investment Research is terminating coverage on Xintela. Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Previously published reports can still be accessed via our website.

Latest Insights

Healthcare | Update

Xintela — Approaching major milestones

Healthcare | Initiation

Xintela — Advancing integrins as innovation engine

Share Price Performance

Financials

Edison Investment Research is terminating coverage on Xintela (XINT), TXT e-solutions (TXT), HUTCHMED (HCM) and Schaltbau Holding (SLT). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Thematics

thematic

Healthcare

Deutsches Eigenkapitalforum (EKF) 2023 healthcare

volition01

thematic

Healthcare

VolitionRx – Decoding the DNA of cancer 

thematic

Healthcare

ASCO 2023 key takeaways

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free